Bebt-908
C23H28Cl3N9O3S — CID 163203562
Data last refreshed: (MolForge compound catalog, from PubChem)
About Bebt-908
Bebt-908 (PubChem CID 163203562) has the molecular formula C23H28Cl3N9O3S and a molecular weight of 616.96 g/mol. Its IUPAC name is N-hydroxy-2-[methyl-[[2-[6-(methylamino)-3-pyridinyl]-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]amino]pyrimidine-5-carboxamide;trihydrochloride.
Molecular Properties
| Compound Name | Bebt-908 |
|---|---|
| PubChem CID | 163203562 |
| Molecular Formula | C23H28Cl3N9O3S |
| Molecular Weight | 616.96 g/mol |
| Exact Mass | 615.11 |
| IUPAC Name | N-hydroxy-2-[methyl-[[2-[6-(methylamino)-3-pyridinyl]-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]amino]pyrimidine-5-carboxamide;trihydrochloride |
| SMILES | CNc1ccc(-c2nc(N3CCOCC3)c3sc(CN(C)c4ncc(C(=O)NO)cn4)cc3n2)cn1.Cl.Cl.Cl |
| InChI | InChI=1S/C23H25N9O3S.3ClH/c1-24-18-4-3-14(10-25-18)20-28-17-9-16(36-19(17)21(29-20)32-5-7-35-8-6-32)13-31(2)23-26-11-15(12-27-23)22(33)30-34;;;/h3-4,9-12,34H,5-8,13H2,1-2H3,(H,24,25)(H,30,33);3*1H |
| InChIKey | XQJBSJNJWWXTFM-UHFFFAOYSA-N |
| XLogP | 3.44 |
| TPSA | 141.52 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 616.96 |
| LogP ≤ 5 | 3.44 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 12 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'hydroxamic_acid', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 163203562 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.